GROUP ONE TRADING, L.P. - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 86 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2020. The put-call ratio across all filers is 0.18 and the average weighting 1.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$34,0000.0%2850.0%0.00%
Q4 2020$34,000
+78.9%
285
+70.7%
0.00%
Q3 2020$19,000
+850.0%
167
+659.1%
0.00%
Q1 2020$2,000
-100.0%
22
-100.0%
0.00%
-100.0%
Q3 2019$8,011,000
+496.9%
69,986
+397.1%
0.06%
+441.7%
Q2 2019$1,342,000
+886.8%
14,078
+842.9%
0.01%
+500.0%
Q1 2019$136,000
-83.4%
1,493
-86.2%
0.00%
-71.4%
Q4 2018$820,00010,8080.01%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q1 2020
NameSharesValueWeighting ↓
Maso Capital Partners Ltd 627,111$74,068,00020.20%
Athos Capital Ltd 362,909$42,863,00011.81%
PSquared Asset Management AG 205,000$24,213,0003.85%
York Capital Management Global Advisors, LLC 302,675$35,749,0003.52%
HHLR ADVISORS, LTD. 2,962,076$349,851,0002.78%
ALPINE ASSOCIATES MANAGEMENT INC. 534,180$63,092,0002.58%
Pentwater Capital Management LP 1,178,000$139,134,0001.68%
Temasek Holdings (Private) Ltd 1,240,000$146,456,0000.63%
AQR Arbitrage LLC 142,733$16,858,0000.59%
FORT, L.P. 9,761$1,153,0000.34%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders